JG
ASMB icon

Jefferies Group’s Assembly Biosciences ASMB Stock Holding History

Jefferies Group’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,583
Closed -$1.02M – 1311
2020
Q1 		$1.02M Buy
5,583
+2,569
+85% +$551K 0.01% 990
2019
Q4 		$740K Buy
3,014
+2,063
+217% +$380K 0.01% 1613
2019
Q3 		$112K Buy
+951
New +$144K ﹤0.01% 2485

Other funds holding ASMB

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jefferies Group's ASMB Position: Q2 2020 in Review

Jefferies Group sold out of Assembly Biosciences (ASMB) in Q2 2020, closing a stake of 5,583 shares — an estimated $1.02M sold.

Jefferies Group first reported a position in ASMB in Q3 2019 and held it in 3 quarters. The position peaked at $1.02M in Q1 2020. 106 funds tracked by Wall St. Rank hold ASMB as of Q2 2020.

  • Jefferies Group reported no remaining Assembly Biosciences position as of Q2 2020 after selling out during the quarter.
  • Jefferies Group sold 5,583 Assembly Biosciences shares in Q2 2020, an estimated $1.02M.
  • Jefferies Group first reported a position in Assembly Biosciences in Q3 2019 and held it in 3 quarters.
  • Jefferies Group's Assembly Biosciences position peaked at $1.02M in Q1 2020.
  • 106 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2020.

Based on Jefferies Group's 13F filing for Q2 2020, filed 14 Aug 2020.